Page 86 - Read Online
P. 86

Author Instructions

           9. Editorial Process
           9.1 Initial check
           9.1.1 Initial manuscript check
           New submissions are initially checked by the Managing Editor from the perspectives of originality, suitability, structure
           and formatting, conflicts of interest, background of authors, etc. Poorly-prepared manuscripts may be rejected at this stage.
           If your manuscript does not meet one or more of these requirements, we will return it for further revisions.

           9.1.2 Publishing ethics
           All manuscripts submitted to RDODJ are screened using iThenticate powered by CrossCheck to identify any plagiarized
           content. Your study must also meet all ethical requirements as outlined in our Editorial Policies. If the manuscript does not
           pass any of these checks, we may return it to you for further revisions or decline to consider your study for publication.
           9.2 Editorial assessment
           Once your manuscript has passed the initial manuscript check, it will be assigned to an Assistant Editor, and then the
           Editor-in-Chief, or an Associate Editor in the case of a conflict of interest, will be notified of the submission and invited to
           review. Regarding Special Issue paper, after passing the initial check, the manuscript will be successively assigned to an
           Assistant Editor, Guest Editor, and then to the Editor-in-Chief, or an Associate Editor in the case of conflict of interest for
           the Editor-in-Chief to review. The Editor-in-Chief, or the Associate Editor may reject manuscripts that they deem highly
           unlikely to pass peer review without further consultation. Once your manuscript has passed the editorial assessment, the
           Assistant Editor will start to organize peer-review.

           9.3 Process
           RDODJ operates a single-blind review process. The technical quality of the research described in the manuscript is assessed
           by a minimum of three independent expert reviewers. The Editor-in-Chief is responsible for the final decision regarding
           acceptance or rejection of the manuscript. For controversial manuscripts, the Editor-in-Chief is responsible for making the
           final decision.
           9.4 Decisions
           Your research will be judged on technical soundness only, not on its perceived impact as judged by Editors or referees.
           There are three possible decisions: Accept (your study satisfies all publication criteria), Invitation to Revise (more work is
           required to satisfy all criteria), and Reject (your study fails to satisfy key criteria and it is highly unlikely that further work
           can address its shortcomings).
           10. Contact Us
           Journal Contact
           Rare Disease and Orphan Drugs Journal Editorial Office
           Suite 1504, Plaza A, Xi’an National Digital Publishing Base, No. 996 Tiangu 7th Road, Gaoxin District, Xi’an 710077,
           Shaanxi, China.
           Tel: +86 (0)29 8954 0089
           Yuan Ding
           Managing Editor
           editorialoffice@rdodjournal.com
           Last updated on 18 March, 2024




























                 Rare Disease and Orphan Drugs Journal
   81   82   83   84   85   86   87